As our nation continues to debate how the healthcare system should be fixed, little attention has been paid to the need to better incorporate multiculturalism in the provision of medical care.
Pharmacy Times launches specialty
November 15, 2010
8:18 pm
Pharmacy Times launched a new title, Specialty Pharmacy Times, which will focus on policy, regulatory and legal issues, as well as product reviews, reimbursement and new clinical trends in specialty pharmacy.
Cancer journal focuses on research
November 15, 2010
8:16 pm
The American Association for Cancer Research (AACR) will launch a new journal–Cancer Discovery–in April 2011.
Allergan shifts sales reps to Botox for its new indication
Allergan sales forces previously working on Glaxo-SmithKline headache drugs Imitrex and Amerge as part of a co-promotion will be reassigned to Botox, in support of the drug’s new headache indication.
Biogen Idec and Elan’s MS drug Tysabri realized a 15% increase in US revenues during the third quarter (compared with Q3 2009), a gain at least partially due to larger sales forces and increased patient assistance programs, according to Biogen Idec executives.
In the name of protecting patients, conflict-of-interest (COI) rules imposed by medical schools and public agencies are actually harming them, according to a report from the Manhattan Institute’s Project FDA.
Pri-Med launched its Open Network, an initiative designed to spur industry-wide innovation in the way professional med ed is developed, delivered and funded.
This time last year, the majority of us were glad to see the back of 2009. The industry welcomed 2010 with an uncertain mix of trepidation, relief, hope and bracing for the worst.
A love-hate relationship for Coumadin is playing out online, say authors of a new report that may offer lessons for marketers of new blood-thinning products.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix